Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD)
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Patients with PTSD, and frequent nightmares, and mild-moderate suicidal ideation, who are
already taking a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine
Reuptake Inhibitor (SNRI) will be randomized to either prazosin or placebo. The investigators
hypothesize that patients receiving prazosin will have a greater reduction in suicidal
ideation.